124 related articles for article (PubMed ID: 12013578)
1. Genetic abnormalities in oligodendroglial and ependymal tumours.
Goussia AC; Kyritsis AP; Mitlianga P; Bruner JM
J Neurol; 2001 Dec; 248(12):1030-5. PubMed ID: 12013578
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas.
Ransom DT; Ritland SR; Kimmel DW; Moertel CA; Dahl RJ; Scheithauer BW; Kelly PJ; Jenkins RB
Genes Chromosomes Cancer; 1992 Nov; 5(4):348-56. PubMed ID: 1283324
[TBL] [Abstract][Full Text] [Related]
3. Karyotypes in 90 human gliomas.
Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R
Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal composition of a series of 22 human low-grade gliomas.
Rey JA; Bello MJ; de Campos JM; Kusak ME; Moreno S
Cancer Genet Cytogenet; 1987 Dec; 29(2):223-37. PubMed ID: 3677044
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the NF2 gene in oligodendrogliomas and ependymomas.
Alonso ME; Bello MJ; Arjona D; Gonzalez-Gomez P; Lomas J; de Campos JM; Kusak ME; Isla A; Rey JA
Cancer Genet Cytogenet; 2002 Apr; 134(1):1-5. PubMed ID: 11996787
[TBL] [Abstract][Full Text] [Related]
6. Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells.
Nijssen PC; Deprez RH; Tijssen CC; Hagemeijer A; Arnoldus EP; Teepen JL; Holl R; Niermeyer MF
J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1245-8. PubMed ID: 7931388
[TBL] [Abstract][Full Text] [Related]
7. The chromosomes in two oligodendrogliomas and three ependymomas in adults.
Mark J
Hereditas; 1971; 69(1):145-9. PubMed ID: 5173417
[No Abstract] [Full Text] [Related]
8. Loss of chromosome 1 in myxopapillary ependymoma suggests a region out of chromosome 22 as critical for tumour biology: a FISH analysis of four cases on touch imprint smears.
Tamiolakis D; Papadopoulos N; Venizelos I; Lambropoulou M; Nikolaidou S; Bolioti S; Kiziridou A; Manavis J; Alexiadis G; Simopoulos C
Cytopathology; 2006 Aug; 17(4):199-204. PubMed ID: 16879268
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic studies of pediatric ependymomas.
Kramer DL; Parmiter AH; Rorke LB; Sutton LN; Biegel JA
J Neurooncol; 1998 Mar; 37(1):25-33. PubMed ID: 9525835
[TBL] [Abstract][Full Text] [Related]
10. Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH.
Jeuken JW; Sprenger SH; Gilhuis J; Teepen HL; Grotenhuis AJ; Wesseling P
J Pathol; 2002 Jun; 197(2):238-44. PubMed ID: 12015749
[TBL] [Abstract][Full Text] [Related]
11. Genetics and imaging of oligodendroglial tumors.
Ellenbogen JR; Walker C; Jenkinson MD
CNS Oncol; 2015; 4(5):307-15. PubMed ID: 26478219
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
13. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
[TBL] [Abstract][Full Text] [Related]
14. A complex karyotype including a t(2;11) in a paediatric ependymoma: case report and review of the literature.
Aschero S; Vallero S; Morra I; Impera L; Forni M; Sandri A; Basso ME; Storlazzi CT; Giordano F; Fidani P; De Ioris MA; di Montezemolo LC
J Neurooncol; 2010 Aug; 99(1):141-6. PubMed ID: 20066474
[TBL] [Abstract][Full Text] [Related]
15. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
16. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic abnormalities in human ependymomas.
Stratton MR; Darling J; Lantos PL; Cooper CS; Reeves BR
Int J Cancer; 1989 Oct; 44(4):579-81. PubMed ID: 2793229
[TBL] [Abstract][Full Text] [Related]
18. Chromosomes in the genesis and progression of ependymomas.
Rogatto SR; Casartelli C; Rainho CA; Barbieri-Neto J
Cancer Genet Cytogenet; 1993 Sep; 69(2):146-52. PubMed ID: 8402555
[TBL] [Abstract][Full Text] [Related]
19. Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas.
Grill J; Avet-Loiseau H; Lellouch-Tubiana A; Sévenet N; Terrier-Lacombe MJ; Vénuat AM; Doz F; Sainte-Rose C; Kalifa C; Vassal G
Cancer Genet Cytogenet; 2002 Jul; 136(2):121-5. PubMed ID: 12237235
[TBL] [Abstract][Full Text] [Related]
20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
